Radityo Prakoso

Dr. Radityo Prakoso

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2020 in Indian Heart Journal
Verified
Journal Article
Open access
PDF file
RPRaymond Pranata
Raymond Pranata
EYEmir Yonas
Emir Yonas
RVRachel Vania
Rachel Vania
RPRadityo Prakoso
Radityo Prakoso
Objective: This systematic review and meta-analysis aimed to synthesize the latest evidence on the efficacy and safety of oral acetaminophen compared to oral ibuprofen for patent ductus arteriosus (PDA) in preterm infants. Methods: We performed a systematic literature search on topics that assesses the use of oral paracetamol compared to oral ibuprofen in preterm neonates diagnosed with PDA from PubMed, EuropePMC, Cochrane Central Database, ScienceDirect, ProQuest, ClinicalTrials.gov, and hand-sampling from potential articles. Results: There were 1547 subjects from 10 selected studies. Primary closure rate was similar in both groups. Subgroup analysis on studies enrolling neonates with ≤30 weeks gestational age showed that ibuprofen was superior (OR 0.52 [0.31, 0.90], I2: 0%). On the other hand, paracetamol was superior neonates with ≤34 weeks gestational age (OR 1.73 [1.01, 2.94], I2: 30%). Reopening rate, surgical closure rate, mortality, intraventricular hemorrhage, and necrotizing enterocolitis were similar in both groups. Rate of renal dysfunction (OR 0.27 [0.10, 0.77], I2: 0%) and gastrointestinal bleeding (OR 0.31 [0.11, 0.88], I2: 0%) were lower in paracetamol group. Subgroup analysis of randomized controlled studies (RCTs) showed similar results. Meta-regression analysis showed that the primary closure rate was not influenced by gestational age, birth weight, and gender. GRADE demonstrates a low level of certainty for primary closure and mortality. Renal dysfunction and gastrointestinal bleeding havea moderate level of certainty. Conclusion: There was no significant difference between the efficacy of oral paracetamol and oral ibuprofen. However, the rate of renal dysfunction and gastrointestinal bleeding were higher in oral ibuprofen.

4 April 2025 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
RPRadityo Prakoso
Radityo Prakoso
RARina Ariani
Rina Ariani
YKYovi Kurniawati
Yovi Kurniawati
SSSisca Natalia Siagian
Sisca Natalia Siagian
ASAditya Agita Sembiring
Aditya Agita Sembiring
OLOktavia Lilyasari
Oktavia Lilyasari
Introduction: Zero-fluoroscopy, exclusively ultrasound-guided atrial septal defect (ASD) catheter closure has been reported. However, data on the effectiveness of this technique in complex cases remains limited.Objectives: This study aims to evaluate the safety, efficacy, and outcomes of ASD catheter closure using exclusive ultrasound guidance, with a particular focus on complex cases.Methods: We conducted a retrospective review of clinical data from patients who underwent attempted ASD catheter closure with exclusive ultrasound guidance at our institution between July 2018 and April 2024. Patients were categorized into two groups based on the complexity of their cases (simple vs. complex ASD cases). Complex cases included patients with large defects (≥25 mm), multiple or fenestrated ASDs, deficient posterior-inferior rim <3 mm, deficient retro-aortic rim <5 mm, pulmonary hypertension, septal malalignment, and pregnancy. We analyzed and compared demographic information, procedural data, and outcomes between the two groups.Results: We identified 339 patients (18.2% males, 53.6% adults) with a median age of 21 years (IQR, 9–38) and median weight of 46.5 Kg (IQR, 22–59). Overall, median defect size was 20 mm (IQR, 16–25) and device size was 26 mm (IQR, 20–32). 248 (73.1%) patients were classified as complex including 98 (28.9%) with large defects (≥25 mm), 33 (9.7%) with multiple or fenestrated ASDs, 53 (15.6%) with pulmonary hypertension, 171 (50.4%) with rim deficiency, 50 (14.7%) with septal malalignment, and 6 (1.7%) with pregnancy. Two procedures (0.5%) were guided using transthoracic ultrasound and 337 (99.4%) using both transthoracic and transoesophageal ultrasound. The implantation success rate was 98.9% in simple cases and 97.1% in complex cases (p < 0.001). The rate of conversion to fluoroscopy guidance was 0 (0%) in simple cases and 7 (2.8%) in complex cases (p < 0.001). The median procedural time was 41 min (IQR, 30–47) in simple cases and 45 min (IQR, 36–62) in complex cases (p = 0.008). Sixteen patients (4.7%) underwent balloon-assisted procedures, and 12 (3.5%) required redeployment. There were 6 (1.7%) serious procedural complications (0 in simple cases, 6 in complex cases). The median follow-up was 187 days (IQR, 21–428.7). There were no residual shunt at latest follow-up for both simple and complex cases.Conclusions: Zero-fluoroscopy exclusively echocardiography-guided ASD closure is effective in both simple and complex cases. However, the rate of conversion to fluoroscopy and implantation failure are significantly higher in complex ASD cases.

1 February 2024 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
RPRadityo Prakoso
Radityo Prakoso
YKYovi Kurniawati
Yovi Kurniawati
SSSisca Natalia Siagian
Sisca Natalia Siagian
ASAditya Agita Sembiring
Aditya Agita Sembiring
DSDamba Dwisepto Aulia Sakti
Damba Dwisepto Aulia Sakti
OLOktavia Lilyasari
Oktavia Lilyasari
Objectives: The purpose of this study was to assess the clinical outcome after right ventricular outflow tract (RVOT) stenting in late presenter patient with unrepaired Fallot physiology.Background: In younger patients, RVOT stenting is an alternative to mBTT shunt; however, there have been few reports of this palliative technique in late presenter population, including adults.Methods: This was a single-center, retrospective study of nonrandomized, palliated Fallot patients. Clinical outcomes such as left ventricular ejection fraction and saturation were measured in 32 individuals following RVOT stenting in adults (n = 10) and children (n = 22). The Statistical Package for Social Science (SPSS) 26.0 software was used to analyze the statistical data.Results: During the procedure, the average stent diameter and length were 8.84 ± 1.64 mm and 35.46 ± 11.23 mm, respectively. Adult patients received slightly longer stents than pediatric patients (43.60 ± 11.64 mm vs. 31.77 ± 9.07 mm). Overall, patients' saturation increased from 58.56 ± 19.03% to 91.03 ± 8.98% (p < 0.001), as did their left ventricular ejection fraction (LVEF) from 64.00 ± 18.21% to 75.09 ± 12.98% (p = 0.001). Three patients improved their LVEF from 31 to 55%, 31 to 67%, and 26 to 50%. The median length of stay was 8 (2–35) days, with an ICU stay of 2 (0–30) days. The median time from RVOT stent palliation to total repair was 3 months (range: 1 month–12 months).Conclusions: RVOT stenting is a safe and effective method for increasing saturation and ejection fraction not only in newborn infants but also in late presenters, including adults with unrepaired Fallot physiology.

1 November 2022 in Current Cardiology Reviews
Verified
Journal Article
Open access
PDF file
BMBrian Mendel
Brian Mendel
CCChristianto Christianto
Christianto Christianto
PAPhoniex Angellia
Phoniex Angellia
IHIndra Holiyono
Indra Holiyono
RPRadityo Prakoso
Radityo Prakoso
SSSisca Siagian
Sisca Siagian
Background: Reversed Potts shunt has been a prospective approach to treat suprasystemic pulmonary hypertension, particularly when medication treatment fails to reduce right ventricular afterload. Objective: This meta-analysis aims to review the clinical, laboratory, and hemodynamic parameters after a reversed Potts shunt in suprasystemic pulmonary hypertension patients. Methods: Six electronic databases were searched from the date of inception to August 2021, where the obtained studies were evaluated according to the PRISMA statement. The effects of shunt creation were evaluated by comparing preprocedural to postprocedural or follow-up parameters, expressed as a mean difference of 99% confidence interval. Quality assessment was conducted using the STROBE statement. Results: Seven studies suited the inclusion criteria which were included in this article. A reduction in upper and lower limb oxygen saturation [Upper limb: St. Mean difference -0.55, 99% CI -1.25 to 0.15; P=0.04; I2=6%. Lower limb: St. Mean difference –4.45, 99% CI –7.37 to –1.52; P<0.00001; I2=65%]. Reversed Potts shunt was shown to improve WHO functional class, 6-minute walk distance, NTpro-BNP level, and hemodynamic parameters including tricuspid annular plane systolic excursion, interventricular septal curvature, and end-diastolic right ventricle/left ventricle ratio. Conclusion: Reversed Potts shunt cannot be said to be relatively safe, although it allows improvement in the clinical and functional status in patients with suprasystemic PAH. Reversed Potts shunt procedure may be the last resort for drug-resistant pulmonary hypertension as it is considered a high-risk procedure performed on patients with extremely poor conditions.

24 October 2024 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
RPRadityo Prakoso
Radityo Prakoso
RDResi Citra Dewi
Resi Citra Dewi
BMBrian Mendel
Brian Mendel
CACelly Anantaria Atmadikoesoemah
Celly Anantaria Atmadikoesoemah
SPSalomo Purba
Salomo Purba
RSRenan Sukmawan\R\N
Renan Sukmawan\R\N
Background: Right ventricular outflow tract (RVOT) stenting as an alternative palliation for patients with stenotic RVOTs is increasingly recognized. However, a notable gap remains in the literature regarding the efficacy and the comparative outcomes between RVOT stenting and the modified Blalock-Taussig shunt (mBTS) in children older than one year.Methods: We conducted a retrospective review of clinical data from patients aged one year to 18 years with stenotic RVOTs who underwent RVOT stenting or mBTS procedures at our institution between December 2019 and October 2022. We compared major adverse cardiovascular events (MACE) including re-hospitalization, re-intervention, and mortality, hospital and ICU length of stay, and discharge oxygen saturation between the groups.Results: We identified 58 patients (51.7% male) with a median age of 2.6 years (IQR: 2–8.1) and a median weight of 9.7 kg (IQR: 7.5–17.5). Among them, 18 (31%) patients received RVOT stenting, and 40 (68.9%) patients had mBTS. The median age for the RVOT stenting group was 92.5 months (IQR: 31.2–152) compared to 26.5 months (IQR: 23.0–54.0) for the mBTS group (p = 0.218). MACEs occurred in 4 (22.2%) patients with RVOT stents and 8 (20%) patients with mBTS (p = 0.624). Patients with mBTS had a longer ICU stay (median 3.5 days, IQR, 2–5) compared to those with RVOT stents (median 2 days, IQR: 1–2) (p = 0.295). Conversely, the hospital stay for patients with mBTS was shorter (median 10 days, IQR, 7.5–13.7) than for those with RVOT stents (median 11.5 days, IQR, 7–19) (p = 0.045). The median discharge oxygen saturation was 87% (IQR: 83–88) in the mBTS group and 80% (IQR: 75–87) in the RVOT stenting group (p = 0.212).Conclusions: RVOT stenting as palliation to stenotic RVOTs in children older than one year demonstrated outcomes comparable to mBTS in terms of MACE and achieving oxygen saturation targets.

30 November 2022 in High Blood Pressure & Cardiovascular Prevention
Verified
Journal Article
Closed access
PDF file
HEHendrianus
Hendrianus
SASuko Adiarto
Suko Adiarto
RPRadityo Prakoso
Radityo Prakoso
IFIsman Firdaus
Isman Firdaus
SISuci Indriani
Suci Indriani
RSRenan Sukmawan
Renan Sukmawan